Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Torcetrapib/Atorvastatin vs Ezetimibe/Simvastatin in Dyslipidemia
NCT00267267Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of torcetrapib in dyslipidemia, sponsored by Pfizer. Started Jan 2006; status: terminated.
02
Drugs
torcetrapib
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00267267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00267267.